conditions

Cureus Updates Terms & Conditions to Prohibit AI Use

SAN FRANCISCO, Sept. 4, 2025 /PRNewswire/ -- In an era dominated by artificial intelligence, the Cureus Journal of Medical Science…

18 hours ago

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsiesData include an…

1 week ago

NEXEN TIRE Introduces CuttingEdge High Dynamic Driving Simulator to Accelerate Tire Development

First in the Korean tire industry to adopt a High Dynamic Driving Simulator, enabling virtual driving environmentsIncreased precision in tire…

2 weeks ago

India’s business sentiment shows cautious optimism in Q3 2025, with medium enterprises leading investment confidence amid global uncertainty

MUMBAI, India, Aug. 21, 2025 /PRNewswire/ -- A recent survey on Financial Confidence and Investment Confidence, conducted by Dun & Bradstreet…

2 weeks ago

NEXEN TIRE Accelerates Growth in Australian SUV and Pickup Truck Market with Launch of ROADIAN ATX

Strengthening presence through localized product offerings, expanded logistics infrastructure, and strategic sports marketingSEOUL, South Korea, August 18, 2025 – NEXEN…

3 weeks ago

Mumm Cordon Rouge Stellar takes champagne into space

The first champagne crafted for conditions of zero gravity celebrates a historic mission into space REIMS, France, July 24, 2025…

1 month ago

Scaling Self-Care Can Be a Game-Changer in Global Fight Against Non-Communicable Diseases

Ahead of the upcoming UN General Assembly to set a new vision for non-communicable diseases, the Global Self-Care Federation is…

2 months ago

ParkOhio Prices $350 Million Senior Secured Notes Offering

CLEVELAND, OHIO--(BUSINESS WIRE)--Park-Ohio Industries, Inc. (the “Company”), a subsidiary of Park-Ohio Holdings Corp. (NASDAQ: PKOH), today announced that it has…

2 months ago

Cango Inc. Announces Results of Second Extraordinary General Meeting

HONG KONG, July 17, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that all resolutions…

2 months ago

Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital

CHICAGO, July 16, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch today with…

2 months ago